SCHEMBL17837860

SCHEMBL17837860

CO/C=C(/OC)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28781856 1.00
SCHEMBL17837861 1.00
SCHEMBL17857686 0.78 ALDH1A1 (0.38)
SCHEMBL10782279 0.78 ALDH1A1 (0.38)
SCHEMBL26171166 0.78 ALDH1A1 (0.38)
SCHEMBL210278 0.77
SCHEMBL4426723 0.77
SCHEMBL28306121 0.76
SCHEMBL27938072 0.76
SCHEMBL10710391 0.75 MGAM (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116969971-A Nitrogen-containing macrocyclic compound, and preparation method and medical application thereof 中国医药研究开发中心有限公司 2023-10-31 CN disclosed
US-20210087206-A1 MACROCYCLIC KINASE INHIBITORS AND THEIR USE TURNING POINT THERAPEUTICS INC (US) 2021-03-25 US disclosed
EP-3233829-B1 PYRIMIDINE AND TRIAZINE DERIVATIVES AND THEIR USE AS AXL INHIBITORS PFIZER (US) 2019-08-14 EP disclosed
US-9593097-B2 Axl inhibitors PFIZER INC. (US) 2017-03-14 US disclosed
US-20160176850-A1 AXL INHIBITORS PFIZER INC. 2016-06-23 US disclosed